Preview Mode Links will not work in preview mode

This Week in Cardiology

Jul 22, 2022

Therapeutic fashion and conduction system pacing, early rhythm control in AF, statins in CKD, and salt intake in HF are the topics discussed by John Mandrola, MD, in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I – Therapeutic Fashion and Conduction System Pacing

- Medical Necessity vs Therapeutic Fashion: How Evidence-Based Is Your Field of Medicine?

- Conduction System Pacing Noninferior to Biventricular Pacing for HF With Wide QRS

- His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure

II – Early Rhythm Control

- Benefit of Early Rhythm Control Questioned in Newly Diagnosed Atrial Fibrillation

- Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy

- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

III – Statins and CKD

- Rosuvastatin Again Linked With Risks to Kidneys

- Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria

- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

IV – Sodium and HF

- Overly Tight Sodium Restriction May Worsen HFpEF Outcomes

- Salt restriction and risk of adverse outcomes in heart failure with preserved ejection fraction

- Spironolactone for Heart Failure with Preserved Ejection Fraction

- Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact